Neurocysticercosis as an important differential of paradoxical response during antituberculosis therapy in HIV-negative patient

Asian Pacific Journal of Tropical Disease

Volumn 1, Issue 4, 2011, Pages 333-334

  Rakotoarivelo, Rivonirina Andry ^a   Andrianasolo, Radonirina Lazasoa ^a   Ranoharison, Dina ^a   Rakoto, Rado Olivier Sedson ^a   Sendrasoa, Fandresena Arilala ^a   de Dieu Randria, Mamy Jean ^a  

^a Joseph Raseta Hospital   (Madagascar)

Author keywords

Neurocysticercosis; Paradoxical response; Tuberculosis

Indexed keywords

ALBENDAZOLE; CORTICOSTEROID; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBODY DETECTION; ARTICLE; BLURRED VISION; BRAIN EDEMA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DYSARTHRIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; GLASGOW COMA SCALE; HEADACHE; HEMIANOPIA; HOSPITAL READMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUMBAR PUNCTURE; MAINTENANCE THERAPY; MALE; NEUROCYSTICERCOSIS; PARADOXICAL DRUG REACTION; PARESIS; PRIORITY JOURNAL; TREATMENT DURATION; TUBERCULOUS MENINGITIS; VOMITING; WESTERN BLOTTING;

EID: 84856848146     PISSN: 22221808     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2222-1808(11)60077-7     Document Type: Article

References (14)

1. Kimura-Hayama ET, Higuera JA, Corona-Cedillo R, Chavez-Macias L, Perochena A, Quiroz-Rojas LY, et al. Neurocysticercosis: radiologic-pathologic correlation. Radiographics 2010, 30:1705-1719.
2. Coyle CM, Tanowitz HB Diagnosis and treatment of neurocysticercosis. Interdiscip Perspect Infect Dis 2009, 2009:180742.
3. Cheng VCC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PCY, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002, 21:803-809.
4. Cheng SL, Wang HC, Yang PC Paradoxical response during antituberculosis treatment in HIV-negative patient with pulmonary tuberculosis. Int J Tuberc Lung Dis 2011, 11(12):1290-1295.
5. Gupta A, Singhal S A case of multiple tuberculomas in brain presenting as hemiparesis. Asian Pac J Trop Dis 2011, 1:83-84.
6. Sinha S, Sharma BS Neurocysticercosis: a review of current and management. J Clin Neurosci 2009, 16:867-876.
7. Nicolls DJ, King M, Holland D, Bala J, del Rio C Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis 2005, 5:795-801.
8. Anuradha HK, Garg RK, Sinha MK, Agarwal A, Verma R, Singh MK, et al. Intracranial tuberculomas in patients with tuberculous meningitis: predictors and prognostic significance. Int J Tuberc Lung Dis 2011, 15(2):234-239.
9. Monga PK, Dhaliwal U Paradoxical reaction in tubercular meningitis resulting in involvement of optic radiation. Indian J Ophtalmol 2009, 57(2):139-141.
10. Lorent N, Sebatunzi O, Mukeshimana G, Van den Ende J, Clerinx J Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study. PLoS One 2011, 6(5):e19566.
11. Chakraborty A, Panja S, Bhattacharjee I, Chandra G, Hati A A longitudinal study of neurocysticercosis through CT scan of the brain. Asian Pac J Trop Dis 2011, 1:206-208.
12. Zou XW, Sun BD, Chen XL, Liu XZ, Che YS Helotialins A-C, anti-HIV metabolites from a helotialean ascomycete. Chin J Nat Med 2009, 7(2):140-144.
13. Tian RR, Chen JC, Zhang GH, Qiu MH, Wang YH, Du Li, et al. Anti-HIV-1 activities of hemslecins A and B. Chin J Nat Med 2008, 6(3):214-218.
14. Garcia HH, Evans CAW, Hash TE, Takayanagui OM, Botero D, Rajshekhar V, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002, 15(4):747-756.